Who to call at Lifecore Biomedical, Inc., and when
Fundz watches for the moments Lifecore Biomedical, Inc. starts buying, and tells you who to reach.
- An alert the day Lifecore Biomedical, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lifecore Biomedical, Inc., from your own LinkedIn network
Lifecore Biomedical, Inc.
The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.
www.lifecore.comAI Executive Summary
AI-powered analysis of 8-K filing content
Lifecore Biomedical, Inc. entered into a merger agreement with Lifecore Inc. and Hazel Merger Sub, Inc. on September 27, 2026, whereby Lifecore Biomedical will become a wholly owned subsidiary of Lifecore Inc., backed by Webster Equity Partners. This strategic transaction marks a significant corporate restructuring in the biopharmaceutical sector.
Key Takeaways
Lifecore Biomedical agreed to merge with Lifecore Inc., with Hazel Merger Sub serving as the acquisition vehicle
Webster Equity Partners is the financial sponsor behind Lifecore Inc., indicating private equity involvement
2 more takeaways
Filing Overview
What This Means
Lifecore Biomedical, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.